The Latest Analyst Ratings for 89bio
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for 89bio (NASDAQ:ETNB) within the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the stock is $35.83, which has increased by 3.35% over the past month.
September 22, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
89bio (NASDAQ:ETNB) has received positive ratings from analysts, with an increasing 12-month price target. This could potentially lead to a positive short-term impact on the stock.
Analysts have given 89bio positive ratings, indicating a bullish sentiment towards the stock. Additionally, the average 12-month price target has increased over the past month, suggesting that analysts expect the stock price to rise. This could potentially lead to a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100